Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Fat-selective weight loss would be an additional advantage, as the STEP-1 (NCT03548935) trial demonstrated that once-weekly semaglutide 2.4 mg resulted in 3.4 kg (7.5 lb) more loss in lean body mass compared to placebo
Meanwhile, naltrexone, originally used for addiction treatment, counters the addictive nature of food by blocking certain receptors
The approved dose range for type 2 diabetes is 2.5 mg to 15 mg weekly, identical to the weight-loss range
Our personalized formulations cater to individual needs, enhancing positive outcomes
Targeted by Retatrutide and other weight loss medications, producing appetite suppression and metabolic benefits
US$ 21.75
US$ 24.72
US$ 27.54
